跳至主要内容
临床试验/NCT04092556
NCT04092556Unknown不适用

Exploratory Study to Evaluate the Effective Site for Control of Motor Coordination Function After Transcranial Direct Current Stimulation in Multiple Systemic Atrophy With Cerebellar Feature

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2019年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
10
试验地点
1
主要终点
Change from International Cooperative Ataxia Rating Scale (ICARS)

研究概览

简要总结

The aim of study is to investigate most effective site for control the motor coordination using transcranial direct current stimulation in multiple system atrophy with cerebellar feature

详细描述

Participants receive transcranial direct current stimulation (tDCS) over M1, cerebellar cortex or sham stimulation for 30 minutes. The type of stimulation depends on random assignment. The participants have a 1 week of wash out period between each stimulation.

The assessment will be done by International Cooperative Ataxia Rating Scale (ICARS), GAITRITE (CIR Systems Inc., Clifton, New Jersey, USA) and PEDOSCAN (DIERS PEDO, Germany) at baseline and immediately after each treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients who meet the clinical criteria for probable multiple system atrophy with cerebellar features (MDS second consensus statement on the diagnosis of multiple system atrophy)
  • •Patients aged between 40 and 70
  • •Patients who do not have rigidity and bradykinesia
  • •Patients who have given voluntary consent after understanding the content of the clinical trial

排除标准

  • •Patients with a serious cognitive disorder, behavioral disorder, or mental illness
  • •Patients have history of seizure, stroke, encephalitis, other degenerative neurological disease
  • •Patients with a serious medical disease
  • •Patients who concomitantly suffer from severe renal impairment, convulsions, stomach ulcers, moderate or more severe liver disease
  • •Patients with un-controlled high blood pressure or diabetes
  • •Patients who have taken another investigational products within 4 weeks prior to being enrolled in this clinical trial, or patients who are pregnant or breastfeeding

研究组 & 干预措施

tDCS (M1)

Active Comparator

The participants will be submit to tDCS applied over the motor cortex (M1)

干预措施: transcranial direct current stimulation (Device)

tDCS (Cerebellar cortex)

Active Comparator

The participants will be submit to tDCS applied over the cerebellar cortex

干预措施: transcranial direct current stimulation (Device)

Sham stimulation

Sham Comparator

The participants will be submit to sham stimulation

干预措施: transcranial direct current stimulation (Device)

结局指标

主要结局

Change from International Cooperative Ataxia Rating Scale (ICARS)

时间窗: per session: at baseline and within 30 minutes tDCS treatment completion

The scale is scored out of 100 with 19 items and 4 subscales of postural and gait disturbances, limb ataxia, dysarthria, and oculomotor disorders. Higher scores indicate higher levels of impairment.

次要结局

  • Change from posturography(per session: at baseline and within 30 minutes tDCS treatment completion)
  • Change from temporospatial parameters of gait(per session: at baseline and within 30 minutes tDCS treatment completion)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jinyoung Youn

Associate Professor

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验